Transcendtherapeutics
Senior Associate, Clinical Operations
New York City · Senior
Sponsorship not specified$70k-$100kDetected 216 days ago
GCPClinical TrialsClinical ResearchFDA RegulatoryResearchCommunication
About the role
- The Senior Associate, Clinical Operations is a key member of the Clinical Operations team, with responsibility for supporting the operational aspects of one or more clinical trials.
- This position is highly visible in a small, growing organization which may provide for the opportunity for rapid advancement.
- Assist clinical team during all phases of a clinical study (feasibility, start-up, maintenance, and close-out)
Responsibilities
- The Senior Associate will support the Clinical Trial Manager, CRAs, and the investigational sites.
- Support field-based clinical research associates
- Create and maintain study trackers (e.g., contact lists, study status trackers, enrollment)
- Review and maintain documents in the Trial Master File (TMF)
- Support internal data review, as needed
- Able to effectively communicate and collaborate across functions and job levels
Requirements
- Additional responsibilities as required
- At least 1 year of clinical research experience within a pharmaceutical company or CRO or at least 3 years of experience as a clinical research coordinator
- Proficient knowledge of GCP/ICH, drug development process, clinical operations
Nice to have
- Experience in conducting studies in psychiatry-related indications is preferred
Skills
- Excellent verbal, written, communication and interpersonal skills
Compensation
- We offer competitive cash and equity compensation; medical, dental, and vision insurance; 401k; unlimited vacation and sick time; and more.
Benefits
- We offer competitive cash and equity compensation; medical, dental, and vision insurance; 401k; unlimited vacation and sick time; and more.
- The salary range for this role is $70,000 to $100,000, plus equity and benefits.
- Internally motivated, with a passion for mental health
Company info
- New York City
- Company Overview
- Founded in 2021, Transcend Therapeutics is a late-clinical-stage neuroscience company developing rapid-acting treatments for neuropsychiatric diseases.
- Our lead asset TSND-201, a rapid-acting neuroplastogen, is the first and only product to demonstrate rapid, robust, and durable therapeutic effects in PTSD.
- TSND-201 was granted Breakthrough Therapy designation by the FDA based on Phase 2 results, and we have aligned on a Phase 3 program for TSND-201 in PTSD.
- Transcend is backed by leading life sciences investors and driven by a mission to create treatments for the millions of people for whom current psychiatric medicines have not worked.
Apply directly at Transcendtherapeutics →Create a free account for alerts like thisView Transcendtherapeutics immigration profile
This listing is sourced directly from Transcendtherapeutics's careers page and normalized into a canonical job model.